This series on “Neoadjuvant/Adjuvant Treatment for Early Breast Cancer” is edited by Dr. Fabien Maldonado and Dr. Robert Lentz, from Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.
It is our sincere hope that these state-of-the-art reviews on relevant and debated topics in lung nodule management will stimulate discussions, encourage research and inform clinical decisions to hopefully ultimately improve patient care. We believe that thoughtful and cautious implementation of these novel strategies will eventually contribute to clarify the nature of indeterminate lung lesions, or at least reduce uncertainty to a manageable level.
Reducing uncertainty to a manageable level: the need for a nuanced and patient-centric approach to lung nodule management in the 21st century
Evaluating the efficacy of bronchoscopy for the diagnosis of early stage lung cancer
Bronchoscopic biopsy of peripheral pulmonary lesions in 2020: a review of existing technologies
Navigational bronchoscopy: a guide through history, current use, and developing technology
Cone beam navigation bronchoscopy: the next frontier
Robotic bronchoscopy for pulmonary lesions: a review of existing technologies and clinical data
Bronchoscopic tissue yield for advanced molecular testing: are we getting enough?
Approaches to lung nodule risk assessment: clinician intuition versus prediction models
Do we need to see to believe?—radiomics for lung nodule classification and lung cancer risk stratification
Noninvasive biomarkers for lung cancer diagnosis, where do we stand?
Standardizing education in interventional pulmonology in the midst of technological change
Disclosure:
The series “Novel Diagnostic Techniques for Lung Cancer” was commissioned by the Editorial office, Journal of Thoracic Disease without any sponsorship or funding. Fabien Maldonado and Robert J. Lentz served as the unpaid Guest Editors for the series.